Raymond James Trust’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $27.2M | Buy |
84,519
+18,921
| +29% | +$6.19M | 0.59% | 35 |
|
|
2024
Q2 | $20.5M | Sell |
65,598
-828
| -1% | -$243K | 0.48% | 47 |
|
|
2024
Q1 | $18.9M | Sell |
66,426
-4,354
| -6% | -$1.27M | 0.46% | 54 |
|
|
2023
Q4 | $20.4M | Buy |
70,780
+443
| +0.6% | +$121K | 0.54% | 44 |
|
|
2023
Q3 | $18.9M | Buy |
70,337
+4,306
| +7% | +$1.07M | 0.56% | 40 |
|
|
2023
Q2 | $14.7M | Buy |
66,031
+410
| +0.6% | +$95.1K | 0.42% | 57 |
|
|
2023
Q1 | $15.9M | Buy |
65,621
+2,026
| +3% | +$497K | 0.5% | 47 |
|
|
2022
Q4 | $16.7M | Sell |
63,595
-1,599
| -2% | -$429K | 0.56% | 41 |
|
|
2022
Q3 | $14.7M | Buy |
65,194
+4,103
| +7% | +$995K | 0.55% | 41 |
|
|
2022
Q2 | $14.9M | Sell |
61,091
-1,319
| -2% | -$323K | 0.53% | 43 |
|
|
2022
Q1 | $15.1M | Sell |
62,410
-109
| -0.2% | -$25K | 0.46% | 53 |
|
|
2021
Q4 | $14.1M | Sell |
62,519
-1,227
| -2% | -$259K | 0.42% | 58 |
|
|
2021
Q3 | $13.6M | Sell |
63,746
-1,358
| -2% | -$313K | 0.45% | 51 |
|
|
2021
Q2 | $15.9M | Sell |
65,104
-5,502
| -8% | -$1.35M | 0.53% | 47 |
|
|
2021
Q1 | $17.6M | Buy |
70,606
+1,734
| +3% | +$414K | 0.61% | 38 |
|
|
2020
Q4 | $15.8M | Sell |
68,872
-3,074
| -4% | -$709K | 0.61% | 42 |
|
|
2020
Q3 | $18.3M | Buy |
71,946
+3,243
| +5% | +$803K | 0.79% | 28 |
|
|
2020
Q2 | $16.2M | Buy |
68,703
+3,811
| +6% | +$870K | 0.78% | 28 |
|
|
2020
Q1 | $13.2M | Buy |
64,892
+6,071
| +10% | +$1.33M | 0.78% | 26 |
|
|
2019
Q4 | $14.2M | Buy |
58,821
+2,546
| +5% | +$561K | 0.68% | 34 |
|
|
2019
Q3 | $10.9M | Buy |
56,275
+1,895
| +3% | +$364K | 0.56% | 43 |
|
|
2019
Q2 | $10M | Buy |
54,380
+1,463
| +3% | +$262K | 0.55% | 47 |
|
|
2019
Q1 | $10.1M | Sell |
52,917
-1,228
| -2% | -$235K | 0.58% | 42 |
|
|
2018
Q4 | $10.5M | Buy |
54,145
+120
| +0.2% | +$23.4K | 0.68% | 35 |
|
|
2018
Q3 | $11.2M | Buy |
54,025
+475
| +0.9% | +$93.6K | 0.63% | 36 |
|
|
2018
Q2 | $9.88M | Buy |
53,550
+472
| +0.9% | +$83.5K | 0.6% | 43 |
|
|
2018
Q1 | $9.05M | Sell |
53,078
-36
| -0.1% | -$6.61K | 0.62% | 40 |
|
|
2017
Q4 | $9.24M | Buy |
53,114
+4,190
| +9% | +$742K | 0.62% | 44 |
|
|
2017
Q3 | $9.12M | Buy |
48,924
+4,067
| +9% | +$721K | 0.65% | 37 |
|
|
2017
Q2 | $7.73M | Buy |
44,857
+3,822
| +9% | +$622K | 0.58% | 44 |
|
|
2017
Q1 | $6.73M | Buy |
41,035
+1,461
| +4% | +$243K | 0.51% | 48 |
|
|
2016
Q4 | $5.79M | Buy |
39,574
+2,447
| +7% | +$368K | 0.46% | 54 |
|
|
2016
Q3 | $6.19M | Buy |
37,127
+324
| +0.9% | +$54.8K | 0.53% | 46 |
|
|
2016
Q2 | $5.6M | Buy |
36,803
+8,185
| +29% | +$1.27M | 0.49% | 55 |
|
|
2016
Q1 | $4.29M | Buy |
28,618
+10,704
| +60% | +$1.59M | 0.4% | 65 |
|
|
2015
Q4 | $2.91M | Buy |
17,914
+1,955
| +12% | +$307K | 0.27% | 90 |
|
|
2015
Q3 | $2.21M | Buy |
15,959
+1,770
| +12% | +$279K | 0.25% | 98 |
|
|
2015
Q2 | $2.18M | Sell |
14,189
-15
| -0.1% | -$2.4K | 0.23% | 102 |
|
|
2015
Q1 | $2.27M | Sell |
14,204
-290
| -2% | -$45.7K | 0.24% | 97 |
|
|
2014
Q4 | $2.31M | Buy |
14,494
+3,212
| +28% | +$500K | 0.25% | 94 |
|
|
2014
Q3 | $1.58M | Buy |
11,282
+1,351
| +14% | +$176K | 0.18% | 125 |
|
|
2014
Q2 | $1.18M | Sell |
9,931
-338
| -3% | -$39.1K | 0.13% | 158 |
|
|
2014
Q1 | $1.27M | Buy |
10,269
+528
| +5% | +$64K | 0.16% | 140 |
|
|
2013
Q4 | $1.11M | Buy |
9,741
+635
| +7% | +$72.2K | 0.15% | 150 |
|
|
2013
Q3 | $1.02M | Buy |
9,106
+446
| +5% | +$48.4K | 0.16% | 146 |
|
|
2013
Q2 | $855K | Buy |
+8,660
| New | +$899K | 0.14% | 158 |
|
Other funds holding AMGN
Raymond James Trust's AMGN Position: Q3 2024 in Review
Raymond James Trust increased its Amgen (AMGN) stake by 29% in Q3 2024, buying an estimated $6.19M and bringing the position to 84,519 shares worth $27.2M. The position accounts for 0.59% of the portfolio, ranked #35.
Raymond James Trust first reported a position in AMGN in Q2 2013 and has held it in 46 quarters since. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.
- Raymond James Trust held 84,519 shares of Amgen worth $27.2M as of Q3 2024.
- Raymond James Trust bought 18,921 Amgen shares in Q3 2024, an estimated $6.19M.
- Amgen made up 0.59% of Raymond James Trust's portfolio in Q3 2024, its #35 holding.
- Raymond James Trust first reported a position in Amgen in Q2 2013 and has held it in 46 quarters since.
- 2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.
Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.